Allevas Extended Release Tablets 150 mg (Revamipide)

Adult dose

Adults should take 1 tablet twice a day, once in the morning and once in the evening. This medication should be swallowed whole and should not be split or chewed.

This medicine should not be used by patients who have had an allergic reaction to any ingredient of this drug. In clinical trials, side effects such as gastrointestinal disturbances, infections, and myalgia have been reported, most of which were mild symptoms. Rarely, symptoms such as dizziness, headache, skin rash, and indigestion may occur, and if symptoms are severe, consultation with a healthcare professional is advised. If serious allergic reactions, liver function abnormalities, or blood disorders occur, discontinue use immediately and visit a hospital. Women who are pregnant or may become pregnant should exercise caution when using this drug, and it is advisable to avoid breastfeeding while taking this medication. Safety has not been sufficiently confirmed for children and adolescents, so caution is required. The elderly may be more sensitive to side effects such as gastrointestinal symptoms due to decreased body function, so careful monitoring is necessary. This medication should be kept out of reach of children, and transferring it to another container should be avoided to prevent quality degradation or accident risks.

Serious side effects

• Hives
• severe swelling (edema)
• shock
• anaphylaxis-like symptoms
• difficulty breathing
• thrombocytopenia
• leukopenia
• liver dysfunction
• yellowing of the skin or eyes (jaundice)
• severe allergic reactions

Mild side effects

Gastrointestinal disturbances (nausea, abdominal distension, upper abdominal pain, constipation, diarrhea, indigestion), infections and parasitic issues (nasopharyngitis, epididymitis, pharyngotonsillitis), musculoskeletal and connective tissue disorders (myalgia, arthralgia), neurological disorders (dizziness, headache), skin and subcutaneous tissue disorders (dry skin, dermatitis, pruritus), psychological disorders (depression, insomnia), respiratory disorders (cough, oropharyngeal pain), blood and lymphatic system disorders (leukopenia.

This drug is susceptible to air and moisture, so it must be stored in a tightly sealed container. The storage temperature should be maintained at room temperature between 1°C and 30°C. Proper storage will safely preserve the drug's effectiveness.

Appearance

White elongated extended release tablet

Package unit

Bottle packaging - 30 tablets/bottle, Bottle packaging - 300 tablets/bottle